Yuntao Wan

836 total citations
19 papers, 697 citations indexed

About

Yuntao Wan is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuntao Wan has authored 19 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuntao Wan's work include Chemokine receptors and signaling (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (3 papers). Yuntao Wan is often cited by papers focused on Chemokine receptors and signaling (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (3 papers). Yuntao Wan collaborates with scholars based in United States, China and Switzerland. Yuntao Wan's co-authors include Shelby P. Umland, Himanshu Shah, Charles G. Garlisi, Jun Zou, Robert W. Egan, Eric L. Gustafson, Kristine Devito, Feng Zhu, Motasim Billah and James Jakway and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuntao Wan

19 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuntao Wan United States 13 296 273 257 128 121 19 697
Ben M. de Koster Netherlands 16 192 0.6× 222 0.8× 249 1.0× 97 0.8× 39 0.3× 40 622
Lenox D. Martin United States 10 186 0.6× 247 0.9× 172 0.7× 32 0.3× 244 2.0× 15 692
Ignacio Fajardo Spain 13 123 0.4× 389 1.4× 323 1.3× 125 1.0× 63 0.5× 19 745
Mariko Nishiyama Japan 15 128 0.4× 145 0.5× 439 1.7× 51 0.4× 182 1.5× 36 804
Greg King Australia 10 571 1.9× 141 0.5× 191 0.7× 78 0.6× 63 0.5× 17 924
Mark L. Richards United States 20 181 0.6× 315 1.2× 510 2.0× 129 1.0× 109 0.9× 32 1.1k
Margaret E. Martin United States 8 139 0.5× 287 1.1× 529 2.1× 202 1.6× 72 0.6× 10 1.1k
R. A. Lutz United States 11 115 0.4× 136 0.5× 318 1.2× 34 0.3× 115 1.0× 13 684
Adelyne Chan United Kingdom 12 157 0.5× 161 0.6× 244 0.9× 104 0.8× 98 0.8× 19 542
B. Mainprice France 8 116 0.4× 159 0.6× 149 0.6× 53 0.4× 61 0.5× 9 426

Countries citing papers authored by Yuntao Wan

Since Specialization
Citations

This map shows the geographic impact of Yuntao Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuntao Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuntao Wan more than expected).

Fields of papers citing papers by Yuntao Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuntao Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuntao Wan. The network helps show where Yuntao Wan may publish in the future.

Co-authorship network of co-authors of Yuntao Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuntao Wan. A scholar is included among the top collaborators of Yuntao Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuntao Wan. Yuntao Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Liu, Yong, et al.. (2014). The impact of co‐administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers. British Journal of Clinical Pharmacology. 78(5). 1050–1057. 22 indexed citations
3.
Wan, Yuntao, et al.. (2012). Growth and optical properties of Cr3+-doped CdWO4 single crystals. Chinese Optics Letters. 10(4). 42301–42301. 4 indexed citations
4.
O’Mara, Edward, Claudia Kasserra, John Huddlestone, et al.. (2010). Effect of Vicriviroc on the QT/Corrected QT Interval and Central Nervous System in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 54(6). 2448–2454. 9 indexed citations
5.
Ting, Pauline C., Jie Wu, Shelby P. Umland, et al.. (2005). The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1375–1378. 24 indexed citations
6.
Ting, Pauline C., Shelby P. Umland, Robert Aslanian, et al.. (2005). The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: Antagonists versus agonists. Bioorganic & Medicinal Chemistry Letters. 15(12). 3020–3023. 15 indexed citations
7.
Zou, Jun, Feng Zhu, Jianjun Liu, et al.. (2004). Catalytic Activity of Human ADAM33. Journal of Biological Chemistry. 279(11). 9818–9830. 90 indexed citations
8.
Corboz, Michel R., Charles A. Rizzo, Maria A. Rivelli, et al.. (2003). Pharmacological characterization of α2‐adrenoceptor‐mediated responses in pig nasal mucosa. Autonomic and Autacoid Pharmacology. 23(4). 208–219. 19 indexed citations
9.
Umland, Shelby P., Charles G. Garlisi, Himanshu Shah, et al.. (2003). Human ADAM33 Messenger RNA Expression Profile and Post-Transcriptional Regulation. American Journal of Respiratory Cell and Molecular Biology. 29(5). 571–582. 80 indexed citations
10.
Umland, Shelby P., Yuntao Wan, Himanshu Shah, et al.. (2003). Mouse ADAM33. American Journal of Respiratory Cell and Molecular Biology. 30(4). 530–539. 12 indexed citations
11.
Garlisi, Charles G., Jun Zou, Kristine Devito, et al.. (2003). Human ADAM33: protein maturation and localization. Biochemical and Biophysical Research Communications. 301(1). 35–43. 50 indexed citations
12.
Zou, Jun, Simon Young, Feng Zhu, et al.. (2002). Identification of Differentially Expressed Genes in a Monkey Model of Allergic Asthma by Microarray Technology. CHEST Journal. 121(3). 26S–27S. 12 indexed citations
13.
Wan, Yuntao, James Jakway, Hongchen Qiu, et al.. (2002). Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPγS binding. European Journal of Pharmacology. 456(1-3). 1–10. 23 indexed citations
14.
Zou, Jun, Simon Young, Feng Zhu, et al.. (2002). Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome biology. 3(5). research0020–research0020. 85 indexed citations
15.
Rizzo, Charles A., Michel R. Corboz, Shelby P. Umland, et al.. (2001). Postjunctional α2C-adrenoceptor contractility in human saphenous vein. European Journal of Pharmacology. 413(2-3). 263–269. 12 indexed citations
16.
Umland, Shelby P., Yuntao Wan, Himanshu Shah, et al.. (2001). Receptor reserve analysis of the human α2C-adrenoceptor using [35S]GTPγS and cAMP functional assays. European Journal of Pharmacology. 411(3). 211–221. 18 indexed citations
17.
Morse, Kelley L., Thomas M. Laz, Robert E. West, et al.. (2001). Cloning and Characterization of a Novel Human Histamine Receptor. Journal of Pharmacology and Experimental Therapeutics. 296(3). 1058–1066. 169 indexed citations
18.
Jonakait, G. Miller, Wen Yang, Yuntao Wan, & Li Ni. (2000). Macrophage Cell-Conditioned Medium Promotes Cholinergic Differentiation of Undifferentiated Progenitors and Synergizes with Nerve Growth Factor Action in the Developing Basal Forebrain. Experimental Neurology. 161(1). 285–296. 32 indexed citations
19.
Umland, Shelby P., Yuntao Wan, Himanshu Shah, et al.. (2000). Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells. Journal of Leukocyte Biology. 67(3). 441–447. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben M. de Koster Breakdown of academic impact, for papers by Lenox D. Martin Breakdown of academic impact, for papers by Ignacio Fajardo Breakdown of academic impact, for papers by Mariko Nishiyama Breakdown of academic impact, for papers by Greg King Breakdown of academic impact, for papers by Mark L. Richards Breakdown of academic impact, for papers by Margaret E. Martin Breakdown of academic impact, for papers by R. A. Lutz Breakdown of academic impact, for papers by Adelyne Chan Breakdown of academic impact, for papers by B. Mainprice
Rankless by CCL
2026